Renaissance Technologies LLC acquired a new position in shares of Anterix Inc. (NASDAQ:ATEX – Free Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 33,700 shares of the company’s stock, valued at approximately $1,334,000. Renaissance Technologies LLC owned 0.18% of Anterix as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also modified their holdings of ATEX. SG Americas Securities LLC purchased a new stake in shares of Anterix in the second quarter valued at about $1,520,000. Gamco Investors INC. ET AL raised its holdings in Anterix by 24.2% in the first quarter. Gamco Investors INC. ET AL now owns 93,295 shares of the company’s stock valued at $3,136,000 after acquiring an additional 18,195 shares in the last quarter. Bank of New York Mellon Corp increased its stake in Anterix by 8.0% in the second quarter. Bank of New York Mellon Corp now owns 50,605 shares of the company’s stock valued at $2,003,000 after purchasing an additional 3,752 shares during the last quarter. Vanguard Group Inc. increased its stake in Anterix by 0.9% in the first quarter. Vanguard Group Inc. now owns 876,015 shares of the company’s stock valued at $29,443,000 after purchasing an additional 8,020 shares during the last quarter. Finally, Woodmont Investment Counsel LLC increased its stake in Anterix by 4.2% in the first quarter. Woodmont Investment Counsel LLC now owns 32,248 shares of the company’s stock valued at $1,084,000 after purchasing an additional 1,314 shares during the last quarter. Hedge funds and other institutional investors own 87.67% of the company’s stock.
Anterix Price Performance
NASDAQ:ATEX opened at $35.66 on Friday. The firm’s fifty day moving average price is $37.67 and its 200 day moving average price is $35.38. Anterix Inc. has a 1-year low of $28.70 and a 1-year high of $42.41. The firm has a market cap of $662.17 million, a price-to-earnings ratio of -72.78 and a beta of 0.83.
Analyst Upgrades and Downgrades
Separately, JPMorgan Chase & Co. raised their target price on shares of Anterix from $60.00 to $61.00 and gave the stock an “overweight” rating in a research report on Thursday, August 8th.
Check Out Our Latest Research Report on Anterix
Anterix Profile
Anterix Inc operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and innovative broadband solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico.
Featured Articles
- Five stocks we like better than Anterix
- Health Care Stocks Explained: Why You Might Want to Invest
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
- Why Are Stock Sectors Important to Successful Investing?
- MarketBeat Week in Review – 9/30 – 10/4
- What Are Trending Stocks? Trending Stocks Explained
- Top Streaming Companies: Who’s Winning the Battle?
Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.